- Home
- CERS vs MIY Comparison
CERS vs MIY Comparison
Compare CERS & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MIY
- Stock Information
- Founded
- CERS 1991
- MIY 1992
- Country
- CERS United States
- MIY United States
- Employees
- CERS N/A
- MIY N/A
- Industry
- CERS EDP Services
- MIY Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- MIY Finance
- Exchange
- CERS Nasdaq
- MIY Nasdaq
- Market Cap
- CERS 347.3M
- MIY 324.7M
- IPO Year
- CERS 1997
- MIY N/A
- Fundamental
- Price
- CERS $1.27
- MIY $11.41
- Analyst Decision
- CERS Strong Buy
- MIY
- Analyst Count
- CERS 2
- MIY 0
- Target Price
- CERS $3.50
- MIY N/A
- AVG Volume (30 Days)
- CERS 1.2M
- MIY 56.8K
- Earning Date
- CERS 05-01-2025
- MIY 01-01-0001
- Dividend Yield
- CERS N/A
- MIY 3.98%
- EPS Growth
- CERS N/A
- MIY N/A
- EPS
- CERS N/A
- MIY N/A
- Revenue
- CERS $185,144,000.00
- MIY N/A
- Revenue This Year
- CERS $22.37
- MIY N/A
- Revenue Next Year
- CERS $8.46
- MIY N/A
- P/E Ratio
- CERS N/A
- MIY N/A
- Revenue Growth
- CERS 13.06
- MIY N/A
- 52 Week Low
- CERS $1.12
- MIY $9.45
- 52 Week High
- CERS $2.54
- MIY $11.70
- Technical
- Relative Strength Index (RSI)
- CERS 46.48
- MIY 50.71
- Support Level
- CERS $1.21
- MIY $10.84
- Resistance Level
- CERS $1.35
- MIY $11.44
- Average True Range (ATR)
- CERS 0.06
- MIY 0.16
- MACD
- CERS -0.00
- MIY -0.02
- Stochastic Oscillator
- CERS 38.89
- MIY 64.77
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.